Product Information

CARVEDILOL 3.125 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0168 per EA under NDC 72888003405. Its NADAC has been published 217 times since Jun 29, 2022.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 3.125 MG TABLET

CARVEDILOL
$0.0168per EA

Strength

3.125 mg/1

NDC

72888003405

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078165

FDA Approved

9/5/2007

TE Code

AB

On Market Since

7/29/2021

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 3.125 MG TABLET has been published 217 times since Jun 29, 2022, and over the history we have for it it has declined 12.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0168 per EA
All-time high$0.0200 (Feb 14, 2024)
All-time low$0.0133 (Nov 20, 2024)
52-week high$0.0174
52-week low$0.0163
Median price$0.0173
Average price$0.0174
Largest weekly change-22.2% (Nov 20, 2024)
Weeks tracked217
Tracking sinceJun 29, 2022

Price History

1W

+0.2%

1M

+0.2%

3M

-3.8%

6M

-0.6%

1Y

+0.1%

3Y

-4.3%

5Y

N/A

All

-12.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CARVEDILOL 3.125 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0168 per EA (NDC 72888003405), effective Aug 19, 2026.

How has the price of CARVEDILOL 3.125 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 12.5%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?

Since Jun 29, 2022, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0200 (Feb 14, 2024), with a median of $0.0173 per EA.

Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 3.125 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 3.125 MG TABLET?

CARVEDILOL 3.125 MG TABLET (NDC 72888003405) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.